Renal and related cancers

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

MicroRNA expression profiles classify human cancers.

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

MicroRNA signatures in human cancers

Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

Why do cancers have high aerobic glycolysis?

Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

Renal clearance of quantum dots